Bond, Rhonda

Contact Information

Email:	mailto:rhondaj.bond@vumc.org
Fax:

To update contact information, please visit the Data Management and Coordinating Center.

Open Protocols

None Available.

Closed Protocols

No closed protocols.

Publications

Publication Name	PubMed ID	Journal
A 3q gene signature associated with triple negative breast cancer organ specific metastasis and response to neoadjuvant chemotherapy.	28387221	Sci Rep
A blood-based proteomic classifier for the molecular characterization of pulmonary nodules.	24132637	Sci Transl Med
Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis.	25247519	JAMA
Advanced imaging (positron emission tomography and magnetic resonance imaging) and image-guided biopsy in initial staging and monitoring of therapy of lung cancer.	23708067	Cancer J
Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.	27615397	J Thorac Oncol
Autoantibody Signature Enhances the Positive Predictive Power of Computed Tomography and Nodule-Based Risk Models for Detection of Lung Cancer.	27615397	J Thorac Oncol
Biomarkers of risk to develop lung cancer in the new screening era.	27195276	Ann Transl Med
Biomarkers to the rescue in a lung nodule epidemic.	24516023	J. Clin. Oncol.
Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity.	25073001	Am. J. Respir. Crit. Care Med.
Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial.	27509046	PLoS ONE
Early detection of NSCLC with scFv selected against IgM autoantibody.	23585862	PLoS ONE
Identification of Proteomic Features To Distinguish Benign Pulmonary Nodules from Lung Adenocarcinoma.	28731711	J. Proteome Res.
Indeterminate pulmonary nodules: risk for having or for developing lung cancer?	25348855	Cancer Prev Res (Phila)
Inhibition of the Biosynthesis of Prostaglandin E2 By Low-Dose Aspirin: Implications for Adenocarcinoma Metastasis.	27554763	Cancer Prev Res (Phila)
Integrated digital error suppression for improved detection of circulating tumor DNA.	27018799	Nat. Biotechnol.
Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer.	23940286	J. Natl. Cancer Inst.
Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository.	26801409	BMC Pulm Med
Lung cancer screening and smoking cessation: a teachable moment?	24872542	J. Natl. Cancer Inst.
Predicting lung cancer prior to surgical resection in patients with lung nodules.	25170644	J Thorac Oncol
Radiological Image Traits Predictive of Cancer Status in Pulmonary Nodules.	27663588	Clin. Cancer Res.
Reproducibility of Volumetric Computed Tomography of Stable Small Pulmonary Nodules with Implications on Estimated Growth Rate and Optimal Scan Interval.	26379272	PLoS ONE
Secretory IgA from submucosal glands does not compensate for its airway surface deficiency in chronic obstructive pulmonary disease.	26432569	Virchows Arch.
Targeting nucleophosmin 1 represents a rational strategy for radiation sensitization.	25035215	Int. J. Radiat. Oncol. Biol. Phys.
The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer.	27882349	JCI Insight
The Pursuit of Noninvasive Diagnosis of Lung Cancer.	27732989	Semin Respir Crit Care Med
The state of molecular biomarkers for the early detection of lung cancer.	22689914	Cancer Prev Res (Phila)
Toward rapid, high-sensitivity, volume-constrained biomarker quantification and validation using backscattering interferometry.	24954171	Anal. Chem.
Validation of a multiprotein plasma classifier to identify benign lung nodules.	25590604	J Thorac Oncol

To update protocols, publications, biomarkers, or science data, please contact the Informatics Center.